Low dose fluticasone propionate (FP) is more effective than higher doses of beclomethasone dipropionate (BDP) in patients with mild to moderate asthma.

被引：0

|

作者：

Rapheal, GD

Baker, JW

Chervinsky, P

Grossman, J

Goldstein, MF

Rogenes, PR

Edwards, L

Lincourt, WR

机构：

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1998年 / 101卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

24

引用

收藏

页码：S6 / S6

页数：1

相关论文

共 39 条

[1] Asthma severity as a determinant for selecting appropriate doses of fluticasone propionate (FP) or beclomethasone dipropionate (BDP).
Murray, JJ
Friedman, B
Chervinsky, P
Fogarty, C
Baker, JW
Rogenes, PR
Edwards, L
Lincourt, WR
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S232 - S232
[2] Fluticasone propionate vs beclomethasone dipropionate in pediatric patients with moderate asthma.
Melaranci, C
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A631 - A631
[3] FLUTICASONE PROPIONATE V BECLOMETHASONE DIPROPIONATE (BDP) IN MODERATE TO SEVERE ASTHMA
ODRISCOLL, R
[J]. THORAX, 1994, 49 (04) : 385 - 385
[4] Low dose inhaled fluticasone propionate administered once daily or twice daily via the Diskus is as safe and effective as beclomethasone dipropionate in steroid naive patients with asthma.
Selner, J
Boltansky, H
Chervinsky, P
Pearlman, D
Pedinoff, A
Weinstein, S
Wolfe, J
Stevens, A
Prillaman, B
Hamedani, A
Harding, S
Field, E
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1319 - 1319
[5] Hydrofluoroalkane-134A beclomethasone dipropionate is more effective than double dose chlorofluorocarbon beclomethasone dipropionate for the treatment of severe asthma
Obata, H
Ikeda, K
[J]. CHEST, 2005, 128 (04) : 165S - 165S
[6] EFFICACY OF LOW-DOSE CICLESONIDE AND FLUTICASONE PROPIONATE FOR MILD TO MODERATE PERSISTENT ASTHMA
Hashemian, Seyed Mohammad Reza
Jamaati, Hamidreza
Malekmohammad, Majid
[J]. CRITICAL CARE MEDICINE, 2015, 43 (12)
[7] HFA-beclomethasone dipropionate (HFA-BDP) is effective at improving asthma at doses as low as 50mcg
Hampel, F
VandenBurgt, J
Stampone, P
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S64 - S64
[8] EFFICACY AND SAFETY OF FLUTICASONE PROPIONATE (FP) METERED-DOSE INHALER IN PATIENTS WITH MODERATE ASTHMA
WOLFE, J
HAMPEL, F
GOLDSTEIN, M
MENDELSON, L
MUNK, Z
SCHABERG, A
KRAL, K
KELLERMAN, D
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (01) : 186 - 186
[9] Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma
van Noord, JA
Schreurs, AJM
Mol, SJM
Mulder, PGH
[J]. THORAX, 1999, 54 (03) : 207 - 212
[10] A COMPARISON OF CLINICAL PROFILES, MEDICATION USE AND SYMPTOMOLOGY IN ASTHMA PATIENTS PRESCRIBED LOW/MODERATE DOSE FLUTICASONE PROPIONATE/SALMETEROL OR MODERATE/HIGH DOSE FLUTICASONE PROPIONATE
Burke, J. P.
Stanford, R. H.
Polos, P. G.
Astry, C. L.
Riedel, A.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A196 - A196

← 1 2 3 4 →